Melanocortin-related signaling
KPV corresponds to the final three residues of alpha-MSH. Cell experiments compare its responses with alpha-MSH and related ACTH fragments to determine which signals depend on the full peptide.

Compound guide
A pathway-focused guide to molecular mechanisms, published evidence, and the limits of interpretation.
Overview
KPV is the three-amino-acid sequence lysine-proline-valine, corresponding to the C-terminal 11–13 fragment of alpha-melanocyte-stimulating hormone.
Cell studies use KPV to examine melanocortin-related signaling, intracellular calcium responses, and inflammatory-response pathways without assuming that it reproduces the full parent peptide.
The published evidence is primarily cellular and preclinical. A molecular response in cultured cells does not establish a safe or effective human outcome, and controlled human efficacy has not been established.
Research model
These receptors, enzymes, and signaling networks define the primary laboratory questions associated with this research material.
KPV corresponds to the final three residues of alpha-MSH. Cell experiments compare its responses with alpha-MSH and related ACTH fragments to determine which signals depend on the full peptide.
A cultured-cell study reported rapid intracellular-calcium responses to KPV under specific experimental conditions while not detecting a cyclic-AMP increase in the keratinocyte models tested.
KPV is used in laboratory models to examine signaling associated with cellular stress and inflammatory responses. The downstream route may vary by model and remains under investigation.
Research interpretation
KPV corresponds to the final three residues of alpha-MSH.
A cultured-cell study reported rapid intracellular-calcium responses to KPV under specific experimental conditions while not detecting a cyclic-AMP increase in the keratinocyte models tested.
KPV is used in laboratory models to examine signaling associated with cellular stress and inflammatory responses.
The published evidence is primarily cellular and preclinical. A molecular response in cultured cells does not establish a safe or effective human outcome, and controlled human efficacy has not been established.
Read the evidence
One important note
KPV evidence is primarily cellular and preclinical. Published cell responses do not establish safety, efficacy, or a predictable human outcome.
This guide summarizes molecular mechanisms, published evidence, and evidence limits in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.